BANK VONTOBEL/CALL/ABBOTT LABORATORIES/110/0.1/20.09.24 Stock

Warrant

DE000VM3MFH1

Delayed Deutsche Boerse AG 04:33:25 2024-06-03 EDT
0.167 EUR +9.87% Intraday chart for BANK VONTOBEL/CALL/ABBOTT LABORATORIES/110/0.1/20.09.24
1 month-64.65%
3 months-89.37%
Date Price Change
24-06-03 0.167 +9.87%
24-05-31 0.152 -8.98%
24-05-30 0.167 +12.08%
24-05-29 0.149 -3.25%
24-05-28 0.154 -26.67%

Delayed Quote Deutsche Boerse AG

Last update June 03, 2024 at 04:33 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Vontobel Vontobel
WKN VM3MFH
ISINDE000VM3MFH1
Date issued 2023-10-06
Strike 110 $
Maturity 2024-09-20 (110 Days)
Parity 10 : 1
Emission price 0.46
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 1.55
Lowest since issue 0.14
Spread 0.01
Spread %5.41%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
102.2 USD
Average target price
125.4 USD
Spread / Average Target
+22.69%
Consensus